Discuss This Drug

INFLUENZA A VIRUS A/Georgia/12/2022 CRV-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Sydney/1304/2022 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

CHEBI:CHEBI_754379

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

route
INTRAMUSCULAR
marketing_start_date
20240701
package_marketing_start_date
20240701
dosage_form
INJECTION, SUSPENSION
product_type
VACCINE
marketing_category
BLA
active_ingredient_strength
15 ug/.5mL
brand_name
Flucelvax
brand_name_base
Flucelvax
product_ndc
70461-554
application_number
BLA125408
labeler_name
Seqirus Inc.
spl_id
361a8d7b-77c9-4bc9-8a5b-c9383f61610b
active_ingredient_name
INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
package_ndc
70461-554-10
package_description
1 VIAL, MULTI-DOSE in 1 CARTON (70461-554-10) / 5 mL in 1 VIAL, MULTI-DOSE (70461-554-11)
generic_name
INFLUENZA A VIRUS A/Georgia/12/2022 CRV-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Sydney/1304/2022 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class